Bevacizumab: a new way of doing business. Part 2
Crossref DOI link:
Update policy: https://doi.org/10.1007/SPRINGER_CROSSMARK_POLICY
Lotery, Andrew J.
Burdon, Michael A.
Text and Data Mining valid from 2018-11-27
30 October 2018
7 November 2018
27 November 2018
Compliance with ethical standards
The authors declare that they have no conflict of interest.